Tissue versus mechanical mitral valve replacement in patients aged 50-70: a propensity-matched analysis.
Nicholas M FialkaAbeline R WatkinsAbrar AlamRyaan El-AndariJimmy J H KangYongzhe HongSabin J BozsoMichael C MoonJeevan NagendranPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2024)
Survival following mechanical and bioprosthetic MVR in patients 50-70 years of age is similar to up to 15 years of follow-up. Bioprosthetic MVR is associated with an increased risk of repeat MVR. Mechanical MVR is not associated with an increased risk of stroke. Valve selection in this patient population requires diligent consideration of structural valve deterioration and subsequent reoperation risk as well as bleeding and thromboembolic risk.
Keyphrases
- mitral valve
- aortic valve
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- atrial fibrillation
- aortic stenosis
- left atrial
- left ventricular
- aortic valve replacement
- peritoneal dialysis
- heart failure
- transcatheter aortic valve replacement
- coronary artery disease
- patient reported outcomes
- brain injury
- transcatheter aortic valve implantation
- subarachnoid hemorrhage
- cerebral ischemia